This is yet another review endorsing a lifestyle that includes exercise for patients on ADT.
The evidence for the benefit of exercise is strong. The evidence for diet and supplements is not so direct. In that area, the authors extend to patients on ADT what is known to be a heart-health (see chapter on diet in the ADT book) and helpful for women in managing menopausal symptoms.
This article does not have substantially new information on what aspect of lifestyle overall are most significant for patients on ADT, but, it is comprehensive and very readable. The last author of the paper is from the drug company AbbVie, which markets Lupron and, to the credit of the company, they acknowledge that they helped fund and write this report. Interestingly, this reflects a change in the pharmaceutical industries attention to dealing with rather than ignoring or minimizing the side effect burden of ADT.
Moyad MA, Newton RU, Tunn UW, Gruca D. 2016. Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy. Research and reports in urology 8:133-143. www.ncbi.nlm.nih.gov/pubmed/27574584